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Background: Adolescence, due to transient pubertal insulin resistance (IR), is associated with a higher risk for
disturbances of glucose metabolism. The aim of our study was 1) to investigate the prevalence of disturbances of
glucose metabolism, 2) to define gender specific homeostasis model assessment of insulin resistance (HOMA-IR)
thresholds associated with increased cardiometabolic risks and 3) to provide predictors of HOMA-IR.
Methods: The studied cohort consisted of Czech adolescents aged 13.0-17.9 years: 1,518 individuals of general
population and three studied groups according weight category (615 normal weight, 230 overweight and 683
obese). The prevalence of IR, impaired fasting glucose (IFG) and type 2 diabetes was assessed. Risky HOMA-IR
thresholds based on components of metabolic syndrome were investigated. HOMA-IR prediction was calculated
taking into account age, blood pressure, multiple anthropometric, biochemical and hormonal parameters.
Results: In general population cohort, the prevalence of IFG and type 2 diabetes was 7.0% and <0.5%, respectively.
Boys regardless of weight presented significantly higher levels of blood glucose and higher prevalence of IFG than
girls. Obese boys were found more insulin resistant than obese girls. HOMA-IR thresholds of 3.6 for girls and 4.4 for
boys were associated with increased cardiometabolic risks. For both genders, the model of HOMA-IR prediction was
composed of age, BMI, ratio of free triiodthyronine to free thyroxine, gamma-glutamyltransferase activity and levels
of triglycerides and sex hormone-binding globulin.
Conclusions: The type 2 diabetes in adolescents, including those who were obese, was rarely diagnosed. Obese
adolescent boys were at greater risk for IR and for IFG than obese girls. In adolescence, thresholds of HOMA-IR in
contrast to predictors were found gender specific.
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Type 2 diabetesIntroduction
Insulin resistance (IR) together with an impaired insulin
secretion does play a role in the pathogenesis of type 2
diabetes [1]. A degree of IR is influenced by age, gender,
race and ethnicity, a stage of sexual development, total
adiposity and fat distribution [2-4]. To date, there is* Correspondence: ihainer@hotmail.com
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The homeostasis model assessment of insulin resist-
ance (HOMA-IR) is simple method to measure IR [5]
and even in obese children strongly correlates with
the results derived from clamp studies [6]. An identifica-
tion of insulin resistant adolescent is highly important as
the occurrence of type 2 diabetes coincides with the peak
of pubertal IR [7]. The interpretation of HOMA-IR
value is particularly challenging at adolescence. Several
HOMA-IR thresholds to define IR in adolescence have
been suggested [8-11].Med Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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IR. A study of Moran et al. demonstrated a significant
correlation between glucose uptake during insulin clamp
and fasting insulin levels [4]. IR, particularly in girls, has
been shown to be associated with a decreased ratio of
C-peptide to insulin [12].
Patients with impaired fasting glucose (IFG) are re-
ferred to as having prediabetes and they are considered
at risk for future development of type 2 diabetes [13].
Data from National Health and Nutrition Examination
Survey showed that the prevalence of IFG in United
States (US) adolescents was 7.0% [14]. Higher prevalence
of IFG is usually found in obese adolescents than in
normal weight counterparts [14]. The prevalence of
type 2 diabetes in children varies across the world but an
increasing trend due to obesity epidemic is observed. A
higher prevalence of type 2 diabetes is found in the US
children mainly in those of non-White European descent
[15]. In the Northern and Central Europe type 2 diabetes
is still, even in obese children, rarely diagnosed and its
prevalence ranges 0.5 to 1.5% [16-18].
Metabolic syndrome due to IR predisposes affected
individuals to type 2 diabetes. Tresaco et al. showed that
HOMA-IR is a useful tool to detect children and adoles-
cents with this condition [8]. Several studies investigated
predictors of pubertal IR e.g. anthropometric parameters
[19], body composition [20], adipokines [20-22] and several
hormones [23,24].
The first aim of our study was to reveal the prevalence
of IR, IFG and type 2 diabetes in normal weight, over-
weight and obese Czech adolescents, and in a general
population cohort. Second, we aimed to investigate the
effects of gender and weight status on levels of blood
glucose, insulin, C-peptide, C-peptide to insulin ratio
and HOMA-IR. Our third aim was to examine the level
of HOMA-IR in relation to the presence of parameters
defining metabolic syndrome. Finally, we intended to
assess major predictors of HOMA-IR from the whole
cohort of studied Czech adolescents.
Methods
Study population
The cohort for the present study was constituted of Czech
adolescents aged 13.0-17.9 years from the Childhood
Obesity Prevalence And Treatment project which consists
of a general population cohort (all body weight categories)
and of in- and out-patient weight intervention cohort
(overweight and obese individuals only). Analyses were
performed in 1,518 Czech adolescents of general popula-
tion (775 girls, 743 boys; 23.9% of girls and 29.3% of boys
were either overweight or obese) and in three weight
categories: 615 normal weight (322 girls and 293
boys) for Body Mass Index (BMI) 25.–75. percentile
(derived from the general population cohort only), 230overweight (116 girls, 114 boys) for BMI 90.–97. per-
centile and 683 obese (381 girls, 302 boys) for BMI ≥ 97.
percentile for sex and age of the Czech reference
[25]. The overweight and obese groups were consti-
tuted from both the general population cohort and
from the intervention study of the above mentioned
project. A detailed design of the project has already been
described [26].Ethics statement
The study protocol was approved by the Ethical Committee
of the Institute of Endocrinology in Prague and was in
accordance with the Helsinki declaration II. All partici-
pants and their parent(s)/guardian(s) signed an informed
consent before the initiation of study procedures.Clinical examination, anthropometry and body
composition
Following parameters were investigated: age; systolic and
diastolic blood pressure; anthropometric parameters and
indexes {weight, height, waist circumference, abdominal
circumference, hip circumference, arm circumference
and theirs z scores; sagittal abdominal diameter; skin-
folds: suprailiac, biceps, triceps, abdomen and subscapu-
lar; fat assessed by bioimpedance (Tanita BC-418 MA,
Tanita AB 140 MA Viscan, Tanita Corporation, Tokyo,
Japan): trunk fat, total body fat, and visceral fat; indexes:
BMI, BMI z-score, waist-to-hip ratio, waist-to-height
ratio, body adiposity index: [(hip circumference)/((height)
1.5] - 18, a body shape index: waist circumference divided
by BMI2/3 height1/2}.Biochemical and hormonal parameters
We investigated following biochemical parameters:
blood glucose, total cholesterol, high-density lipoprotein
cholesterol, low-density lipoprotein cholesterol, trigly-
ceride (TG), C-peptide, C-reactive protein, uric acid,
activity of alanine aminotransferase, aspartate amino-
transferase and gamma-glutamyl aminotransferase (GMT)
and the following hormonal parameters: insulin, free tri-
iodothyronine (fT3), free thyroxine (fT4), thyroid stimulat-
ing hormone, prolactin, cortisol, dehydroepiandrosterone
sulfate, sex hormone-binding globulin (SHBG), testoster-
one, luteinizing hormone, follicle stimulating hormone,
estradiol, progesterone, adiponectin, adipsin, ghrelin,
glucose insulinotropic peptide, glucagon-like-peptide 1,
glucagon, leptin, plasminogen activator inhibitor-1
(PAI-1), resistin and visfatin. Ratio of fT3 to fT4 was
calculated.
Anthropometric procedures, laboratory assays and
evaluations have been described in a previously pub-
lished paper [26].
Aldhoon-Hainerová et al. Diabetology & Metabolic Syndrome 2014, 6:100 Page 3 of 9
http://www.dmsjournal.com/content/6/1/100Definitions of glucose homeostasis disturbances, IR and
metabolic syndrome
According to the American Diabetes Association IFG is
defined by fasting blood glucose 5.6–6.9 mmol/l and
type 2 diabetes by fasting blood glucose ≥ 7.0 mmol/l
[13]. IR was evaluated by the HOMA-IR that was calcu-
lated by the following formula: fasting plasma insulin
(microunits per liter) × fasting glucose (millimoles per
liter)/22.5 [5]. In order to estimate IR in our cohorts, we
used the thresholds of HOMA-IR > 2.5 and > 4.0 [5,27].
HOMA-IR ≤ 4.0 was shown to be associated with a little
probability of type 2 diabetes development [28]. Para-
meters of the International Diabetes Federation (IDF)
definition of the metabolic syndrome were used in
our analyses [29].
Statistical analyses
To eliminate skewed data distribution and heteroscedasti-
city, the original data were transformed to a Gaussian dis-
tribution by a Box-Cox transformation before further
processing using the statistical software Statgraphics Cen-
turion, version XV from Statpoint Inc. (Herndon, Virginia,
USA). Data were analyzed using non-parametric tests:
Mann–Whitney test (for differences between two inde-
pendent groups) and Kruskal-Wallis multiple comparisons
(for differences among three or more independent
groups). Categorical data were tested by Chi-square test.
The statistical software NCSS 2004 (Kaysville, Utah, 190
USA) were used. P-value (two-tailed) < 0.05 was consid-
ered statistically significant.
In order to detect relationships between HOMA-IR and
studied parameters we applied a multivariate regression
with reduction of dimensionality, known as OPLS [30]. All
subjects that had been assessed for the present study were
used for the prediction of HOMA-IR. Analyses were per-
formed separately for boys and girls. OPLS allowed us to
find a model predicting HOMA-IR based both on the mini-
mum number of widely available parameters but also on
the best predictability. We tested the relevance of individual
variables for the model using a criterion variable import-
ance. At the first stage, all above mentioned parameters,
excluding levels of blood glucose and insulin, were studied
for HOMA-IR prediction. We constructed two models for
HOMA-IR prediction. The first model comprised compo-
nents with the highest predictability. The second model
was based on the first model and aimed at components that
are widely available in clinical practice (clinical model).
The statistical software SIMCA-P + Version 12.0.0.0
from Umetrics AB (Umeå, Sweden) was used for data
analyses. The software enabled us to find the number of
the relevant components utilizing the prediction error
sum of squares and also allowed the detection of multi-
variate non-homogeneities and testing the multivariate
normal distribution and homoscedasticity.Results
Disturbances of glucose metabolism and IR
Basic characteristics and only those parameters, which
were found as major predictors of HOMA-IR, for all
studied groups are presented in Table 1. Between girls
and boys of each studied group, there were no differences
in age and BMI z-score except for BMI z-score in the over-
weight cohort (Table 1). Table 1 also shows the prevalence
of IFG, type 2 diabetes and of IR defined by two thresholds
of HOMA-IR in each cohort. IFG was more common in
boys than in girls regardless of weight status (Table 1).
Significant differences in BMI z-scores, levels of insulin,
C-peptide, C-peptide to insulin ratio (except for the ratio
in overweight vs. obese girls) and HOMA-IR (p = 0.000)
but not in blood glucose level were found when weight
categories were compared between each other (normal
weight vs. overweight; normal weight vs. obese; over-
weight vs. obese) in analyses within each gender (data not
shown). In all cohorts, boys presented significantly greater
level of blood glucose than girls (p = 0.000) (Table 1).
Levels of insulin and C-peptide were significantly higher
in girls than in boys in the normal weight and in the gen-
eral population cohorts (p = 0.001) (Table 1). However,
obese boys had significantly higher insulin, C-peptide and
HOMA-IR than obese girls (Table 1). C-peptide to insulin
ratio gradually decreased with an increasing body weight.
No gender differences in this ratio were noted except for
obese individuals (Table 1).
HOMA-IR thresholds associated with cardiometabolic risks
In both genders, HOMA-IR gradually increased with
increasing number of parameters derived from metabolic
syndrome definition. HOMA-IR of 3.6 for girls and of 4.4
for boys were identified as cut-off values that corresponded
to increased cardiometabolic risks defined as a presence of
three components of metabolic syndrome (Table 2). These
HOMA-IR values represent the 84.0 and 87.0 percentile in
girls and boys of general population, respectively.
HOMA-IR prediction
Out of 68 analyzed parameters, 57 parameters in boys
(43.2% variability of the dependent variable explained by
OPLS method) and 51 parameters in girls (30.1% variability
of the dependent variable explained by OPLS method)
showed a significance to HOMA-IR prediction. At this
stage, we first selected those parameters that presented
with the highest prediction and were more or less shared
by both genders. Similar prediction of most of the studied
anthropometric parameters were found, thus, for the fur-
ther model analyses we only included BMI. In the predict-
ive model, age, BMI, ratio of fT3 to fT4, GMT activity,
levels of TG, SHBG, leptin, PAI-1, ghrelin, adiponectin and
testosterone explained 41.4% of the HOMA-IR in boys. Ex-
cept for the level of testosterone, girls presented with the
Table 1 Baseline characteristics of studied cohorts – general population, normal weight, overweight and obese
Parameter General population Normal weight Overweight Obese
Girls (n = 775) Boys (n = 743) p Girls (n = 322) Boys (n = 293) p Girls (n = 116) Boys (n = 114) p Girls (n = 381) Boys (n = 302) p
Age* (years) 16.02
(15.10;17.00)






























0.280 −0.12 (−0.41; 0.19) −0.15 (−0.39; 0.10) 0.114 1.60 (1.39; 1.60) 1.43 (1.22; 1.66) 0.000 3.53 (2.78; 4.65) 3.50 (2.69; 4.72) 0.506





0.010 9.80 (7.6; 12.17) 8.4 (6.42; 11.61) 0.001 11.84 (9.24; 15.16) 11.30
(8.85; 15.29)





0.75 (0.63; 0.89) 0.69 (0.57; 0.86) 0.000 0.71 (0.60; 0.82) 0.64 (0.53; 0.77) 0.000 0.79 (0.68; 0.91) 0.78 (0.65; 0.92) 0.723 0.92 (0.74; 1.13) 0.94 (0.77; 1.23) 0.040







0.543 10.39 (9.15; 12.13) 10.47 (8.97; 12.41) 0.728 9.50 (8.16; 11.13) 9.52
(7.99; 11.24)
0.814 9.21 (7.73; 11.15) 8.54
(6.98; 10.08)
0.000
TG* (mmol/l) 0.87 (0.67; 1.18) 0.82 (0.63; 1.08) 0.002 0.83 (0.65; 1.19) 0.74 (0.58; 0.92) 0.000 0.90 (0.66; 1.18) 0.94 (0.66; 1.23) 0.714 0.96 (0.74; 1.38) 1.12 (0.82; 1.64) 0.000
GMT* (μkat/l) 0.20 (0.17; 0.25) 0.26
(0.22; 0.337)
0.000 0.19 (0.16; 0.24) 0.25 (0.21; 0.30) 0.000 0.22 (0.18; 0.30) 0.30 (0.25; 0.42) 0.000 0.25 (0.2; 0.32) 0.34 (0.27; 0.51) 0.000









0.000 44.50 (27.99;71.62) 29.49
(21.76; 43.38)






























Leptin* (ng/ml) 4.81 (3.07; 7.29) 0.89 (0.51; 2.18) 0.000 4.02 (2.81; 5.81) 0.63 (0.41; 0.89) 0.000 7.25 (5.27; 9.96) 2.16 (1.21; 3.20) 0.000 9.41 (6.20; 14.69) 5.48 (3.28; 8.32) 0.000
PAI-1* (ng/ml) 2.97 (2.04; 3.94) 3.03 (2.35; 4.10) 0.002 2.64 (1.89; 3.43) 2.79 (2.21; 3.57) 0.033 3.46 (2.45; 4.70) 3.37 (2.74; 4.45) 0.842 4.40 (3.19; 6.19) 4.87 (3.53; 6.76) 0.013
HOMA-IR > 2.5
(n,%)
314 (40.50%) 304 (40.90%) 0.874† 98 (30.40%) 82 (28.00%) 0.505† 58 (50.00%) 59 (51.80%) 0.790† 251 (65.90%) 228 (75.50%) 0.006†
HOMA-IR > 4
(n,%)
84 (10.80%) 106 (14.30%) 0.044† 15 (4.70%) 21 (7.20%) 0.186† 13 (11.20%) 20 (17.50%) 0.170† 111 (29.10%) 133 (44.00%) 0.000†
IFG (n,%) 34 (4.40%) 72 (9.70%) 0.000† 12 (3.70%) 20 (6.80%) 0.084† 2 (1.70%) 15 (13.20%) 0.001† 22 (5.80%) 29 (9.60%) 0.060†
T2DM (n,%) 1 (0.13%) 2 (0.27) ‡ 0 0 --- 0 0 --- 2 (0.50%) 1 (0.30%) ‡
BMI, body mass index; T2DM, type 2 diabetes; FBG, fasting blood glucose; fT3/fT4, ratio of free triiodothyronine to free thyroxine; GMT, gamma-glutamyltransferase; HOMA-IR, homeostasis model assessment of insulin
resistance; IFG, impaired fasting glucose; PAI-1, plasminogen activator inhibitor-1; TG, triglycerides. *Data are described as median, lower and upper quartiles. †Chi-test was used. ‡Not calculated due to small number of






























0 (468/301 girls/boys) 2.12 (1.53; 2.84) 1.90 (1.42; 2.61)
1 ( 381/359 girls/boys) 2.55 (1.80; 3.45) 2.28 (1.65; 3.11)
2 (174/168 girls/boys) 2.85 (2.09; 4.37) 3.19 (2.20; 5.03)
3 (54/76 girls/boys) 3.60 (2.56; 5.69) 4.44 (2.88; 6.25)
4 (4/29 girls/boys) 5.86 (4.90; 9.19) 6.38 (4.26; 7.98)
5 (0/3 girls/boys) --- 7.19 (4.33; 13.93)
HOMA-IR, homeostasis model assessment of insulin resistance. Data are described
as median, lower and upper quartiles.
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plained by 28.9% (Figures 1 and 2). Construction of the
second predictive model was based on inclusion of the
minimum of widely used parameters in clinical practice
such as age, BMI, ratio of fT3 to fT4, GMT activity, levels
of TG and SHBG. The model showed still satisfactory
predictability (37.8% variability of the dependent variable
explained by OPLS method in boys, resp. 20.5% in girls).
Discussion
Disturbances of glucose metabolism and IR
Our study of Czech adolescents presents an overview of
glucose metabolism with respect to different weight cat-
egories and to gender. To date, there are no data onFigure 1 Relationships between HOMA-IR (vector Y) and major predic
a correlation coefficient with the predictive component. T-statistic is a ratio
fT3/fT4, ratio of free triiodothyronine to free thyroxine; GMT, gamma-glutam
insulin resistance; PAI-1, plasminogen activator inhibitor-1; SHBG, sex hormoglucose homeostasis disturbances in Czech adolescents. In
the representative cohort of Czech adolescents, IFG was
found in 7.0% with a higher prevalence in boys than in
girls (9.7 vs. 4.4%). This finding is in accordance with US
data which showed similar overall prevalence of IFG in
adolescents and also higher prevalence in boys than in
girls (10.0% vs. 4.0%) [14]. We further showed that boys
are at greater risk for IFG regardless weight status. Our
results of an overall prevalence of type 2 diabetes in
general population (0.2%) and obese adolescents (0.4%)
indicate that type 2 diabetes is still a rare diagnosis even in
the population of obese Czech adolescents. It is known
that the prevalence varies by ethnicity and that much
greater prevalence of type 2 diabetes is found in the US
non-White European descent [15]. Lower prevalence of
type 2 diabetes may partly be explained by ethnically
homogenous Czech Caucasian population. In contrast to
results from US it has been demonstrated that type 2
diabetes in the Northern and Central Europe is still rarely
diagnosed even in obese children [16]. It is highly interest-
ing that the level of fasting blood glucose was similar across
weight categories but always significantly higher in boys
than in girls. Brandou et al. found that the level of blood
glucose was significantly higher in obese than in normal
weight children but only in prepubertal period [31]. Several
studies concluded that men had tendency towards higher
prevalence of abnormalities of glucose homeostasis than
women [32,33]. A recent study performed on Chinesetors (matrix X) for girls. Ra is a component loading expressed as
of component loading and statistical error. BMI, body mass index;
yl aminotransferase; HOMA-IR, homeostasis model assessment of
ne-binding globulin; TG, triglycerides.
Figure 2 Relationships between HOMA-IR (vector Y) and major predictors (matrix X) for boys. Ra is a component loading expressed as a
correlation coefficient with the predictive component. T-statistic is a ratio of component loading and statistical error. BMI, body mass index;
fT3/fT4, ratio of free triiodothyronine to free thyroxine; GMT, gamma-glutamyl aminotransferase; HOMA-IR, homeostasis model assessment of
insulin resistance; PAI-1, plasminogen activator inhibitor-1; SHBG, sex hormone-binding globulin; TG, triglycerides.
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higher levels of fasting blood glucose in boys in compa-
rison to girls regardless of weight status [20]. Our results
as conclusions of others indicate that the HOMA-IR cut-
off point of 2.5 is not suitable for adolescence [9]. Interest-
ingly, only in the obese group there was a significant gender
difference in the prevalence of IR. This result emphasizes
the fact that obese adolescent boys are at greater risk for
IR than girls of comparable degree of obesity.
It has already been demonstrated by several investi-
gators that gender has an effect on insulin sensitivity
[1,3,4,9,34]. In normal weight Czech adolescents as well as
in the general population cohort, levels of insulin and C-
peptide were found significantly higher in girls than in
boys. This finding would therefore confirm the fact than
at puberty girls tend to be more insulin resistant than
boys. Several studies showed a higher IR in girls than in
boys even after adjustment for weight status, several an-
thropometric parameters, race and ethnicity [1,4]. Accord-
ing to our results, obesity in males led to a significantly
higher levels of insulin, C-peptide, HOMA-IR and lower
C-peptide to insulin ratio than in obese girls. This is in
line with conclusion of Kurtoglu et al. who demonstrated
that HOMA-IR cut-off values in the pubertal stage were
significantly higher in boys than in girls [10].HOMA-IR thresholds associated with cardiometabolic risks
HOMA-IR was shown to be a useful tool to detect
children and adolescents with metabolic syndrome [8].
As expected and in accordance with the study of Chinese
children and teenagers we confirmed the trend of in-
creasing HOMA-IR values with the increasing number
of metabolic syndrome components [35]. At adolescence,
HOMA-IR thresholds of 3.6 for girls and 4.4 for boys
were associated with increased cardiometabolic risks.
In the agreement with the conclusion of Kurtoglu et al.,
we also emphasize the necessity of gender specific cut-off
thresholds [10].
HOMA-IR prediction
According to our findings, a broad variety of parameters
had a predictive power for HOMA-IR. As expected the
majority of studied anthropometric parameters played a
role in the index prediction. Due to the fact that the pre-
diction rate among anthropometric parameters was simi-
lar, only BMI was included for further model assessment.
BMI is widely used in clinical practice, in epidemiological
studies and according to our findings had a comparable
prediction to other anthropometric parameters, e.g. waist
circumference. A study by Bosy-Westphal et al. concluded
that waist circumference and BMI have an equivalent
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The same study also showed that measurement of body
fat mass has no advantage over BMI and waist circumfer-
ence in the prediction of obesity-related metabolic risk
[36]. We are aware of the fact that in normal weight but
insulin resistant subjects other factors than BMI probably
play a role in the development of IR, e.g. fat distribution,
family history. According to our predictive models, age in
girls seemed to be stronger predictor of HOMA-IR than
in boys. Younger age particularly in girls was associated
with higher HOMA-IR. This is probably due to the fact
that younger girls of our cohort were at the peak of IR
associated with puberty.
In our cohort, GMT activity and levels of TG, SHBG,
leptin, PAI-1, ghrelin and adiponectin in both genders
and testosterone in boys were revealed as key compo-
nents in HOMA-IR prediction. A strong correlation
between IR and TG has already been confirmed by sev-
eral studies [37]. Significant associations between IR and
non-alcoholic fatty liver disease as well as similar risk
and protective factors for these two inter-related disor-
ders are known [38,39]. It is well recognized that GMT
activity is a marker of oxidative stress and is associated
with an increased risk of cardiovascular disease and
components of metabolic syndrome [40].
According to our results, testosterone was associated
with HOMA-IR prediction in boys. Testosterone is
usually decreased in obese males than in their lean
counterparts. It has also been shown that glucose dis-
posal was significantly associated with serum testoster-
one, even after controlling for BMI and Tanner stage
and thus, linking the presence of IR with hypogonadism
[41]. The level of SHBG was found as an important
predictor of IR in both genders. A strong correlation
between level of leptin and IR measured by HOMA-IR
even after adjustment for gender and BMI has previously
been shown [42]. In a recently published study, leptin
was also found as a strong and independent predictor of
HOMA-IR in boys and in girls [20]. However, some
authors indicated this relationship due to increased fat
mass [43]. PAI-1 represents an independent risk factor
for cardiovascular diseases and its level and activity is
increased in type 2 diabetics [44]. A study on young adults
demonstrated that PAI-1 concentrations were higher in
subjects with impaired glucose tolerance than in subjects
with normal glucose tolerance even having comparable age,
BMI, waist circumference and fat mass [44]. In relation to
HOMA-IR, ghrelin was another parameter with a predict-
ive power in Czech girls and boys. Bacha et al. suggested
that ghrelin suppression might be another feature of IR
in overweight adolescents [23]. A correlation of adipo-
nectin with IR has already been demonstrated [21,22].
In the analyses, in which all studied parameters had
been taken into account, TSH in both genders, fT4 inboys and fT3 in girls were found to have some predictive
power for HOMA-IR. However, the ratio of fT3 to fT4
had stronger prediction than the above mentioned para-
meters, thus we included this ratio in the predictive
models. Several studies demonstrated that a higher fT3 to
fT4 ratio is associated with various markers of unfavorable
metabolic profile and cardiovascular risk [45].
The existence of such a difference in prediction vari-
ability between boys and girls is rather interesting. Boys
presented with higher prediction in all models regardless
number of components. We assume that this might be
due to the major influence of increased insulin level in
girls as the consequence of pubertal physiological IR.
The major limitation of our study is the lack of data
on the presence of acanthosis nigricans as the clinical
sign of IR and the lack of the assessment of pubertal
status in our adolescents. According to a unique longitu-
dinal study performed in our country in years 1961–
1982, the average age of pubertal maturity was 15.5–16.0
years in boys and 13.0 years in girls [46]. We thus
assume that probably all of the girls and the majority of
boys of our cohort have entered puberty at the time of
investigation.
Conclusions
In conclusion, type 2 diabetes in Czech adolescents even
in obese individuals was rarely diagnosed. Findings of
significantly higher level of blood glucose and higher
prevalence of IFG regardless of weight status in boys than
in girls lead us to a conclusion that adolescent boys in
general are at greater risk of glucose disturbances in
comparison to adolescent girls. This is further supported by
our results that showed obese boys more insulin resistant
than obese girls. In adolescence, HOMA-IR of 3.6 for girls
and of 4.4 for boys were identified as cut-off values that
corresponded to increased cardiometabolic risks. Several
parameters seemed to play a role in HOMA-IR prediction.
Major predictors for both genders were age, BMI, ratio of
fT3 to fT4, GMTactivity and levels of TG and SHBG.
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